{"filing":{"accession_number":"0001493152-26-041333","cik":"0000109657","ticker":"GTBP","company_name":"GT Biopharma, Inc.","form":"8-K","filing_date":"2026-09-03","report_date":"2026-09-02","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315226041333/form8-k.htm"},"events":[{"id":31539,"run_id":28946,"accession_number":"0001493152-26-041333","anchor_item_number":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"GT Biopharma filed Certificates of Elimination for eleven series of preferred stock and a Certificate of Amendment effecting a 1-for-25 reverse stock split with simultaneous reduction in authorized shares from 265 million to 26.5 million. These are charter amendments that materially alter the capital structure and security rights of shareholders. While primarily governance/administrative in nature, the reverse stock split and authorized share reduction are material to investors as they affect share count, ownership percentages, and future dilution capacity.","company_name":"GT Biopharma, Inc.","ticker":"GTBP","filing_date":"2026-09-03","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":34462,"accession_number":"0001493152-26-041333","item_number":null,"item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"GT Biopharma filed Certificates of Elimination for eleven series of preferred stock and a Certificate of Amendment effecting a 1-for-25 reverse stock split with simultaneous reduction in authorized shares from 265 million to 26.5 million. These are charter amendments that materially alter the capital structure and security rights of shareholders. While primarily governance/administrative in nature, the reverse stock split and authorized share reduction are material to investors as they affect share count, ownership percentages, and future dilution capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T15:46:37.210465+00:00","company_name":"GT Biopharma, Inc.","ticker":"GTBP","filing_date":"2026-09-03"}]}